跳至主要内容
临床试验/NCT07466862
NCT07466862尚未招募不适用

CuliCan Study A Multimodal Approach to Mitigate Muscle Mass Loss in Advanced Cancer Patients: Personalized Culinary Advice Addressing Mild to Moderate Muscle Mass Loss

Gali Perel1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2026年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200
试验地点
1
主要终点
Muscle mass loss, assessed by SMI on CT examination, from baseline throughout the 6-month study period. CT scans obtained within a window of up to 2 months after completion of the participant's study participation may be used.

研究概览

简要总结

People with advanced cancer often lose muscle over time. This can make them weaker, more tired, and reduce their quality of life. Many patients also struggle to eat because of changes in taste, smell, or appetite.

This study evaluates a new way to help slow muscle loss and support daily functioning.

The approach combines personalized food and cooking guidance with close nutrition demands support. The goal is to help patients eat better in a way that fits their personal needs.

It is hypothesized that this close, personalized treatment improves muscle loss and the quality of life of adults with advanced cancer who are receiving chemotherapy.

The study focuses on people with mild to moderate muscle mass loss currently undergoing or about to start chemotherapy and aims to slow further decline in their muscle mass.

The approach is designed to be practical and suitable for everyday life during cancer treatment.

About 200 adults with advanced cancer who are receiving, or about to receive, chemotherapy will take part in this study.

The study will take place at the Davidoff Cancer Center in Israel and will last 6 months.

Participants will be randomly assigned to one of two groups. One group will receive standard nutrition care from dietitians as well as ongoing physical activities programing and monitoring.

The other group will receive the same care, plus personalized cooking and food guidance tailored to their taste and smell changes. This group will also receive care based on careful measurements of their body's energy needs, body composition, and muscle strength.

These measurements will help the dietitian to offer more precise and personalized nutrition guidance over time.

Both groups will also receive advice about physical activity. Researchers will follow changes in muscle strength, physical function, nutrition status, and quality of life during the study.

The results will help determine whether personalized food and cooking support can better protect muscle mass and well-being in people with advanced cancer.

详细描述

After the completion of 20 patients in each group, an interim analysis will be performed to evaluate the safety and efficacy of the study. The following committee members will evaluate the results and determine whether the study should continue: Prof. Ilya Kagan, MD, Prof. Carla Prado, PhD, RD, FCAHS and Dr. Noa Gordon, PhD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ambulatory males and females, age ≥ 18 years
  • Performance status (PS) 0-2
  • Patients with non-occlusive, metastatic malignancies of the gastrointestinal, lung, genitourinary, or breast origin (stage 4)
  • Receiving/about to receive chemotherapy treatment
  • Have an estimated life expectancy of at least 6 months
  • At least 4 weeks post major surgery
  • Mild to moderate muscle mass loss based on the SMI measure on compoCT
  • At risk of malnutrition according to the 'Malnutrition Universal Screening Tool' (MUST) (Score ≥2)
  • Able to understand and provide written informed consent
  • Willing and able to complete all study-specific procedures and visits
  • Willing and able (either personally or with the help of family members) to prepare meals according to the adjusted recipes

排除标准

  • Patients suffering from gastrointestinal obstruction
  • Patients with severe dietary restrictions
  • A medical condition that impacts the ability to increase muscle mass, as per the PI decision
  • Uncontrolled thyroid disease
  • Self-reported major dietary restrictions related to the intervention, such as irritable bowel syndrome (IBS)
  • Patients with a history or active eating disorder
  • Pregnant or lactating

研究组 & 干预措施

Oncology Dietitian Standard of Care

Active Comparator

Patient will be treated according to the Davidoff oncology dietitian's standard of care. Patient will also receive a standard physical activity program and monitoring.

干预措施: Oncology Dietitian's Standard of Care (Behavioral)

Personalized Culinary and Nutrition Therapy

Experimental

Patient will be treated according to the oncology dietitian's standard of care, including personalized culinary advice based on their individual taste and smell profile, along with close monitoring and management of their metabolism/physiologic needs (their resting energy expenditure, body composition, and hand strength). Dietitians will provide guidance using specially adapted recipes, professionally adjusted to meet individually profiled taste and smell needs, along with general science-based recommendations for meal preparation. Patient will also receive a standard physical activity program and monitoring.

Sensory alterations (taste and smell) and metabolic/physiological measures (resting energy expenditure, body composition, and hand strength) will be conducted every ±3-6 weeks. Each patient will participate in the study for ±6 months.

干预措施: Personalized Culinary and Nutrition Therapy (Behavioral)

结局指标

主要结局

Muscle mass loss, assessed by SMI on CT examination, from baseline throughout the 6-month study period. CT scans obtained within a window of up to 2 months after completion of the participant's study participation may be used.

时间窗: From baseline throughout the month 6 study period - repeatedly evaluated across the study period between groups and within patient longitudinal changes. CT scans obtained within a window of up to 2 months after completion of the participant's study parti

General quality of life assessed by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), from baseline throughout the 6-month study period.

时间窗: From baseline throughout the month 6 study period - repeatedly evaluated across the study period between groups and within patient longitudinal changes.

General quality of life assessed by the Functional Assessment of Anorexia/Cachexia Treatment (FAACT), from baseline throughout the 6-month study period.

时间窗: From baseline throughout the month 6 study period - repeatedly evaluated across the study period between groups and within patient longitudinal changes.

Food-related quality of life assessed by the QVA Questionnaire, from baseline throughout the 6-month study period.

时间窗: From baseline throughout the month 6 study period - repeatedly evaluated across the study period between groups and within patient longitudinal changes.

次要结局

  • Hospitalization rate throughout the 6-month study period.(From baseline throughout the month 6 study period - repeatedly evaluated across the study period between groups and within patient longitudinal changes.)
  • Muscle function evaluated using the time up and go (TUG) test, from baseline throughout the 6-month study period.(From baseline throughout the month 6 study period - repeatedly evaluated across the study period between groups and within patient longitudinal changes.)
  • Muscle function evaluated using handgrip (HG), from baseline throughout the 6-month study period.(From baseline throughout the month 6 study period - repeatedly evaluate across the study period between groups and within patient longitudinal changes.)
  • Muscle function evaluated using the 6-minute walk (6MW) test, from baseline throughout the 6-month study period.(From baseline throughout the month 6 study period - repeatedly evaluated across the study period between groups and within patient longitudinal changes.)
  • Muscle function evaluated using the sit-to-stand (STS) test, from baseline throughout the 6-month study period.(From baseline throughout the month 6 study period - repeatedly evaluated across the study period between groups and within patient longitudinal changes.)

研究者

发起方
Gali Perel
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Gali Perel

Dr. Gali Perl, MD, Director of Davidoff Day Care Unit, Rabin Medical Center

Rabin Medical Center

研究点 (1)

Loading locations...

相似试验